Overall, these results suggested for the first time an attenuation of TME-promoted β1-integrin/HIF-1α axis by resveratrol treatment, indicating the intracellular mode of action of resveratrol in inducing anti-tumor effect in CRC cells. This evidence concerns the gene HIF1A and colorectal carcinoma.